Loading clinical trials...
Loading clinical trials...
The FAIR-ALS study is to investigate the safety and efficacy of a scavenger treatment of iron deferiprone, which would reduce the brain iron to limit the development of amyotrophic lateral sclerosis. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Lille
Collaborators
NCT07294144 · ALS (Amyotrophic Lateral Sclerosis)
NCT07295990 · ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis
NCT06051123 · ALSFTD, ALS (Amyotrophic Lateral Sclerosis), and more
NCT06856850 · ALS (Amyotrophic Lateral Sclerosis), FTD, and more
NCT07401121 · ALS (Amyotrophic Lateral Sclerosis)
Hôpital Roger Salengro, CHRU de Lille
Lille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions